Atlas Trials

Mutational Analysis as a Prognostic and Predictive Marker of Cardiovascular (CVD) Disease in Patients With Myelodysplasia

Clinical trial NCT04110925 · UNKNOWN

Trial details

NCT number
NCT04110925
Sponsor
Sunnybrook Health Sciences Centre
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
MDSCardiovascular DiseasesInflammation
Start date
2019-09-01
Primary completion
2021-09-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.